ID   CHG-5
AC   CVCL_B267
SY   CHG5
DR   Wikidata; Q54811854
RX   DOI=10.3321/j.issn:1000-5404.1999.12.004;
RX   DOI=10.3321/j.issn:1000-5404.2001.03.006;
RX   PubMed=19781350;
CC   Population: Chinese.
CC   Omics: Proteome analysis by 2D-DE.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3288; Oligodendroglioma
DI   ORDO; Orphanet_251627; Oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 14
//
RX   DOI=10.3321/j.issn:1000-5404.1999.12.004;
RA   Chen Z.-Q., Bian X.-W., Xin R., Yin Y.-S.;
RT   "Establishment and characterization of human glioma cell line CHG-5
RT   and its biological features.";
RL   J. Third Mil. Med. Univ. 21:880-883(1999).
//
RX   DOI=10.3321/j.issn:1000-5404.2001.03.006;
RA   Zhao W., Bian X.-W., Shi J.-Q., Lu J.-Y., Chen Z.-Q.;
RT   "Comparative study on cytoskeleton of human glioma cell line CHG-5 and
RT   SHG-44 in vitro.";
RL   J. Third Mil. Med. Univ. 23:264-267(2001).
//
RX   PubMed=19781350; DOI=10.3760/cma.j.issn.0529-5807.2009.06.013;
RA   Zhao Z.-K., Jiang Z.-M., Liu X.-Z., Qi L.-S., Qin X.-J.;
RT   "Differential proteomics in glioblastoma.";
RL   Zhonghua Bing Li Xue Za Zhi 38:414-417(2009).
//